Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Twist Bioscience Corporation

< Previous 1 2 3 4 5 Next >
Twist Bioscience Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Appoints Chet Gandhi as Chief Information Officer
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Appoints Robert Werner as Chief Accounting Officer
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Launches Portfolio of RNA Sequencing Tools
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at ITF World 2023
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Enters into Third Collaboration with Astellas to Support Antibody Discovery for Immunotherapies
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Launches TCR and CAR Libraries to Enable the Development of Cell Therapies
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Report Fiscal 2023 Second Quarter Financial Results on Friday, May 5, 2023
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Announces Robust Antibody Discovery Services Integrating In Vivo, In Vitro and In Silico Approaches
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Publishes Data on VHH Single Domain Antibody Discovery Using New Methodology on Optofluidic Platform
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Announces Technology Early Access of Enhanced Whole Genome Sequencing Solution at AGBT
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Reports Fiscal First Quarter 2023 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Begins Shipping Commercial Product from Synthetic DNA Manufacturing Factory of the Future
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience and CENTOGENE Launch Three Panels to Advance Rare Disease and Hereditary Cancer Research and Support Diagnostics
From Twist Bioscience Corporation
Via Business Wire
Tickers CNTG TWST
Twist Bioscience and Astellas Enter into Multitarget Antibody Discovery Research Collaboration
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at the 41st Annual J.P. Morgan Health Care Conference
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at 5th Annual Evercore ISI HealthCONx Conference
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2022 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Addresses Misleading Short-Seller Report
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results on Friday, November 18, 2022
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience and Illumina Partner to Produce Robust Exome Panel to Advance Research
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Promotes Patrick Finn, Ph.D., to President and Chief Operating Officer
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Launches Human Sample ID Kit to Track Whole Blood Samples Through Lab Testing Workflow
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Earns 2022 Great Place to Work Certification
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.